Daniele Aloisi

ORCID: 0000-0002-2253-296X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diagnosis and Treatment of Venous Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Lymphatic System and Diseases
  • Sympathectomy and Hyperhidrosis Treatments
  • Renal and Vascular Pathologies
  • Peripheral Artery Disease Management
  • Wound Healing and Treatments
  • Cardiac Health and Mental Health
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Oral health in cancer treatment
  • Sexual function and dysfunction studies
  • Entomological Studies and Ecology
  • Aortic aneurysm repair treatments
  • Medical Imaging and Pathology Studies
  • Systemic Sclerosis and Related Diseases
  • Cancer survivorship and care
  • Aortic Disease and Treatment Approaches
  • Skin Diseases and Diabetes
  • Bone health and treatments
  • Systemic Lupus Erythematosus Research
  • Myofascial pain diagnosis and treatment
  • Vasculitis and related conditions
  • Hormonal and reproductive studies

Ospedale Bellaria
2024

Istituto Dermopatico dell'Immacolata
2022

ORCID
2022

Istituti di Ricovero e Cura a Carattere Scientifico
2022

Policlinico S.Orsola-Malpighi
1995

University of Bologna
1994

University of Pisa
1990

Sulodexide, a highly purified glycosaminoglycan, was investigated for treatment of venous leg ulcers. Patients (n = 235) undergoing local including wound care and compression bandaging, were randomised to receive either sulodexide or matching placebo three months. Primary study endpoint complete ulcer healing after 2 months; secondary endpoints at 3 months the time-course changes areas. The proportion patients with higher (p 0.018) "number needed treat" obtain one additional patient healed 7...

10.1055/s-0037-1613116 article EN Thrombosis and Haemostasis 2002-01-01

Venous ulcers are still today one of the main socioeconomic problems medical interest in terms prevalence, morbidity, and costs to health service. In past, various studies have been carried out identify a systemic pharmacologic treatment able accelerate venous ulcer healing times, but frequently results not satisfac tory. The aim this study was evaluate efficacy sulodexide, drug with profibrinolytic antithrombotic activity, accelerating ulcer's time. Ninety-four patients (32 men 62 women),...

10.1177/000331979905001102 article EN Angiology 1999-11-01

Purpose Lymphoscintigraphy is the criterion-standard method for diagnosing lymphedema, and there no universally standardized imaging modality. In our center, we use a new approach: rest/stress intradermal lymphoscintigraphy. Methods We tested 231 consecutive patients with suspected lymphedema. All were studied after complex physical therapy program to reduce edema. Two doses of 99m Tc-nanocolloid injected intradermally. static planar scans taken at rest following tracer injection. Next,...

10.1097/rlu.0000000000004422 article EN Clinical Nuclear Medicine 2022-09-30

Lipedema is a chronic condition characterized by abnormal deposition of subcutaneous adipose tissue, leading to pain. The lack internationally recognized diagnostic criteria complicates the characterization Physiological parameters such as pain pressure threshold (PPT) represent promising prognostic markers for diagnosing lipedema, yet they remain understudied. This study aimed evaluate reliability and validity two measurements, PPT hand-held sphygmomanometer (HHS) in lipedema.

10.1089/lrb.2024.0058 article EN Lymphatic Research and Biology 2024-12-24

Purpose: Lymphedema is one of the most recurrent problems reported by breast cancer survivors, which negatively affects quality life (QoL). The Upper Limb Quality Life Questionnaire (ULL-27) a tool that assesses QoL in patients with cancer-related lymphedema. At present, an Italian adaptation does not exist. aim this study to perform preliminary cross-cultural validation version ULL-27. Materials and Methods: A forward-backward translation have been performed. One hundred twenty women...

10.1089/lrb.2021.0080 article EN Lymphatic Research and Biology 2022-04-11

Dondi, M.; Fanti, S.; Guidalotti, P. L.; Fabritiis, A. De; Aloisi, D.; Martin, Monetti, N.Author Information

10.1097/00006231-199505000-00014 article EN Nuclear Medicine Communications 1995-05-01
Coming Soon ...